06/18/2025
6:41 PM | Day One Biopharmaceuticals (Issuer)
VASCONCELLES MICHAEL (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
06/18/2025
6:42 PM | Day One Biopharmaceuticals (Issuer)
VASCONCELLES MICHAEL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2025
4:47 PM | Day One Biopharmaceuticals (Issuer)
Josey John A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2025
4:47 PM | Day One Biopharmaceuticals (Issuer)
Holles Natalie C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2025
4:49 PM | Day One Biopharmaceuticals (Issuer)
Nicholson Garry A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2025
4:50 PM | Day One Biopharmaceuticals (Issuer)
Garland J. Scott (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2025
4:51 PM | Day One Biopharmaceuticals (Issuer)
Ramasastry Saira (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2025
4:53 PM | Dable Habib J (Reporting)
Day One Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2025
4:54 PM | Day One Biopharmaceuticals (Issuer)
Grossman William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/19/2025
4:44 PM | Bender Jeremy (Reporting)
Day One Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/19/2025
4:45 PM | Day One Biopharmaceuticals (Issuer)
York Charles N II (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for DAWN and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Day One Biopharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. |
05/19/2025
4:48 PM | Day One Biopharmaceuticals (Issuer)
Dubow Adam (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/19/2025
4:54 PM | Day One Biopharmaceuticals (Issuer)
Merendino Lauren (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/28/2025
4:45 PM | BlackRock, Inc. (Filed by)
Day One Biopharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
04/11/2025
3:01 PM | Day One Biopharmaceuticals (Filer)
| Form DEF 14A | |
04/11/2025
3:03 PM | Day One Biopharmaceuticals (Filer)
| Form DEFA14A | |
04/11/2025
3:06 PM | Day One Biopharmaceuticals (Filer)
| Form ARS | |
03/06/2025
4:02 PM | Day One Biopharmaceuticals (Filer)
| Form 10-K/A | |
02/28/2025
6:50 PM | Day One Biopharmaceuticals (Issuer)
Merendino Lauren (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/21/2025
5:05 PM | Bender Jeremy (Reporting)
Day One Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2025
5:08 PM | Day One Biopharmaceuticals (Issuer)
Dubow Adam (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2025
5:10 PM | Day One Biopharmaceuticals (Issuer)
York Charles N II (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/18/2025
5:02 PM | Bender Jeremy (Reporting)
Day One Biopharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/18/2025
5:04 PM | Day One Biopharmaceuticals (Subject)
York Charles N II (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/18/2025
5:07 PM | Day One Biopharmaceuticals (Subject)
Dubow Adam (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/14/2025
5:31 PM | Day One Biopharmaceuticals (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SCHEDULE 13G/A | |
02/12/2025
8:28 AM | Day One Biopharmaceuticals (Subject)
FMR LLC (Filed by)
| Form SCHEDULE 13G/A | |
01/31/2025
3:33 PM | Day One Biopharmaceuticals (Issuer)
Dubow Adam (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2025
3:36 PM | Bender Jeremy (Reporting)
Day One Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2025
3:38 PM | Day One Biopharmaceuticals (Issuer)
York Charles N II (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/13/2025
7:07 AM | Day One Biopharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/18/2024
3:21 PM | Bender Jeremy (Reporting)
Day One Biopharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/18/2024
3:22 PM | Blackman Samuel C. (Reporting)
Day One Biopharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/08/2024
3:15 PM | Blackman Samuel C. (Reporting)
Day One Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/07/2024
8:24 AM | Day One Biopharmaceuticals (Subject)
FMR LLC (Filed by)
| Form SC 13G/A | |
11/07/2024
8:12 AM | Day One Biopharmaceuticals (Subject)
FMR LLC (Filed by)
| Form SC 13G | |
11/04/2024
4:24 PM | Blackman Samuel C. (Reporting)
Day One Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/12/2024
3:48 PM | Blackman Samuel C. (Reporting)
Day One Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2024
4:53 PM | Bender Jeremy (Reporting)
Day One Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2024
4:59 PM | Blackman Samuel C. (Reporting)
Day One Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2024
5:07 PM | Day One Biopharmaceuticals (Issuer)
York Charles N II (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
[ATTENTION] This Crypto Rocket Is About Launch… (Ad) Every crypto bull market ends with a final surge — the window where fortunes are made fast.
According to two crypto experts, that moment is here. Their Crypto Code Workshop shows how to get positioned before altcoins take off, ride the wave, and lock in gains — with a free $10 Bitcoin bonus just for attending. Join The Crypto Code Workshop + get $10 in Bitcoin for attending |
08/19/2024
5:12 PM | Day One Biopharmaceuticals (Issuer)
Dubow Adam (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/16/2024
4:17 PM | Blackman Samuel C. (Reporting)
Day One Biopharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/16/2024
4:23 PM | Bender Jeremy (Reporting)
Day One Biopharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/30/2024
6:35 AM | Day One Biopharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/30/2024
6:04 AM | Day One Biopharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/25/2024
5:04 AM | Day One Biopharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/16/2024
3:32 PM | Blackman Samuel C. (Reporting)
Day One Biopharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
